Printed From BioPortfolio.com

Celsion announces TARDOX study combining ThermoDox and focused ultrasound to tackle cancers

06:00 EST 21 Nov 2017 | NIHR Oxford Biomedical Research Centre

Celsion Corporation has launched a clinical trial, supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), to study the effectiveness of combining cancer drug ThermoDox with focused ultrasound to treat a range of tumours, including liver cancer The trial was announced on Monday (20 November) with the publication of the manuscript, ... Read more

Original Article: Celsion announces TARDOX study combining ThermoDox and focused ultrasound to tackle cancers

More From BioPortfolio on "Celsion announces TARDOX study combining ThermoDox and focused ultrasound to tackle cancers"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches